{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T08:02:34Z","timestamp":1779264154602,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis Supplements"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.atherosclerosissup.2012.10.005","type":"journal-article","created":{"date-parts":[[2013,1,26]],"date-time":"2013-01-26T17:33:53Z","timestamp":1359221633000},"page":"39-44","source":"Crossref","is-referenced-by-count":53,"title":["Differences in the atherogenic risk of patients treated by lipoprotein apheresis according to their lipid pattern"],"prefix":"10.1016","volume":"14","author":[{"given":"M.","family":"von Dryander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Passauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.R.","family":"Bornstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Julius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00041433-199712000-00003","article-title":"Therapy for lowering lipoprotein(a) levels","volume":"8","author":"Angelin","year":"1997","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jacl.2011.11.003","article-title":"Low density lipoprotein apheresis is effective in reducing lipoprotein(a) levels and in improving symptoms in a patient with refractory angina secondary to accelerated coronary artery disease","volume":"6","author":"Ibrahim","year":"2012","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.transci.2011.11.016","article-title":"Three different LDL apheresis columns efficiently and equally reduce lipoprotein(a) concentrations in patients with familial hypercholesterolemia and small apolipoprotein(a) particles","volume":"46","author":"Hovland","year":"2012","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1744-9987.2009.00747.x","article-title":"Retrospective analysis of long-term lipid apheresis at a single center","volume":"14","author":"Koziolek","year":"2010","journal-title":"Ther Apher"},{"issue":"6","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/11594970-000000000-00000","article-title":"Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia","volume":"11","author":"Lee","year":"2011","journal-title":"Am J Cardiovasc Drugs"},{"issue":"5","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1567-5688(09)71817-3","article-title":"Cardiovascular events in patients with increased lipoprotein(a) \u2013 retrospective data analysis in an outpatient department of lipid disorders","volume":"10","author":"Tselmin","year":"2009","journal-title":"Atheroscler Suppl"},{"issue":"23","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib7","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ncpcardio1456","article-title":"Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events","volume":"6","author":"Jaeger","year":"2009","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0955-3886(95)00048-8","article-title":"LDL-apheresis in treatment of two patients with heterozygous familial hypercholesterolemia and extremely elevated lipoprotein(a) levels","volume":"16","author":"Bambauer","year":"1995","journal-title":"Transfus Sci"},{"issue":"9","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2174\/138161211795428777","article-title":"Lipoprotein(a): medical treatment options for an elusive molecule","volume":"17","author":"Parhofer","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.atherosclerosissup.2012.10.005_bib11","first-page":"535","article-title":"State oft the art treatment oft he most difficult low density lipoprotein (LDL) cholesterol problems: LDL apheresis","volume":"100","author":"Whayne","year":"2002","journal-title":"J Ky Med Assoc"},{"issue":"5","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1567-5688(09)71818-5","article-title":"Designing a study to evaluate the effect of apheresis in patients with elevated lipoprotein(a)","volume":"10","author":"Kassner","year":"2009","journal-title":"Atheroscler Suppl"},{"issue":"1","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0021-9150(93)90068-6","article-title":"Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia","volume":"100","author":"Koizumi","year":"1993","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib14","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0026-0495(98)90278-5","article-title":"Therapeutic efficiency of lipo-protein(a) reduction by low density lipoprotein immunoapheresis","volume":"47","author":"Banyai","year":"1998","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00002480-199909000-00008","article-title":"LDL-apheresis as long-term treatment in severe hyperlipidemia using differing methods","volume":"45","author":"Bambauer","year":"1999","journal-title":"ASAIO J"},{"issue":"12","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1046\/j.1365-2362.1998.00395.x","article-title":"DALI-the first human whole-blood low-density lipoprotein and lipoprotein(a) apheresis system in clinical use: procedure and clinical results","volume":"28","author":"Drager","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.atherosclerosissup.2012.10.005_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.transci.2009.10.003","article-title":"Treatment of symptomatic hyperLp(a)lipidemia with LDL-apheresis vs. usual care","volume":"42","author":"Stefanutti","year":"2010","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.atherosclerosissup.2012.10.005_bib18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(95)92961-4","article-title":"The familial hypercholesterolaemia regression study: a randomized trial of low-density-lipoprotein apheresis","volume":"345","author":"Thompson","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosissup.2012.10.005_bib19","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.CIR.93.10.1826","article-title":"LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis","volume":"93","author":"Kroon","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosissup.2012.10.005_bib20","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0002-9149(98)00692-4","article-title":"Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia","volume":"82","author":"Mabuchi","year":"1998","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1744-9987.1998.tb00075.x","article-title":"Short-term and long-term effects of low-density lipoprotein (LDL) apheresis on restenosis after percutaneous transluminal coronary angioplasty (PTCA): is lowering Lp(a) by by LDL apheresis effective on restenosis after PTCA?","volume":"2","author":"Kanemitsu","year":"1998","journal-title":"Ther Apher"},{"key":"10.1016\/j.atherosclerosissup.2012.10.005_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0009-3084(94)90162-7","article-title":"Effectiveness of LDL-apheresis in preventing restenosis after percutaneous transluminal coronary angioplasty (PTCA): LDL-apheresis angioplasty restenosis trial (L-ART)","volume":"67-68","author":"Yamaguchi","year":"1994","journal-title":"Chem Phys Lipids"},{"issue":"3","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1744-9987.1998.tb00106.x","article-title":"Can aggressive lipid lowering using low-density lipoprotein apheresis prevent restenosis after percutaneous transluminal coronary angioplasty in patients with normocholesterolemia?","volume":"2","author":"Yamashita","year":"1998","journal-title":"Ther Apher"},{"issue":"12","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.7326\/0003-4819-125-12-199612150-00001","article-title":"Effect of apheresis of low density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease","volume":"125","author":"Kroon","year":"1996","journal-title":"Ann Intern Med"},{"issue":"4A","key":"10.1016\/j.atherosclerosissup.2012.10.005_bib25","doi-asserted-by":"crossref","first-page":"67E","DOI":"10.1016\/j.amjcard.2005.06.012","article-title":"Role of low-density lipoprotein (LDL) apheresis","volume":"96","author":"Ziajka","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.005_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1567-5688(09)71803-3","article-title":"The Dresden Apheresis Center \u2013 experience with LDL apheresis and immunoadsorption","volume":"10","author":"Julius","year":"2009","journal-title":"Atheroscler Suppl"}],"container-title":["Atherosclerosis Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567568812000165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567568812000165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T05:32:09Z","timestamp":1539927129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567568812000165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1567568812000165"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosissup.2012.10.005","relation":{},"ISSN":["1567-5688"],"issn-type":[{"value":"1567-5688","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}